Magdalena Klánová

Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety

Wolfgang Hiddemann, Anna Maria Barbui, Miguel Canales et al. · Journal of Clinical Oncology · 2018 · 226 citations · Full text

Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL

Magdalena Klánová, Laurie H. Sehn, Isabelle Bence‐Bruckler et al. · Blood · 2019 · 124 citations · Full text

Targeting of BCL2 Family Proteins with ABT-199 and Homoharringtonine Reveals BCL2- and MCL1-Dependent Subgroups of Diffuse Large B-Cell Lymphoma

Magdalena Klánová, Ladislav Anděra, Jan Bražina et al. · Clinical Cancer Research · 2015 · 99 citations

Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal <i>In Vivo</i> in Relapsed Mantle Cell Lymphoma

Dana Průková, Ladislav Anděra, Zuzana Nahácka et al. · Clinical Cancer Research · 2019 · 72 citations

Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy

Magdalena Klánová, Mikkel Z. Oestergaard, Marek Trněný et al. · Clinical Cancer Research · 2019 · 69 citations

Immunohematology, Immunodeficiencies, Immunology +22